Pharmacology and Toxicology Department Highlights: January 2022

Jan. 1, 2022
A researcher using a syringe.

(January 1, 2022)

Publications

Biochemical genesis of enzymatic and non-enzymatic post-translational modifications Molecular Aspects of Medicine (2021) PMID:34838336 Online ahead of print

Vemurafenib Drives Epithelial-to-Mesenchymal Transition Gene Expression in BRAF Inhibitor‒Resistant BRAF V600E/NRAS Q61K Melanoma Enhancing Tumor Growth and Metastasis in a Bioluminescent Murine Model Journal of Investigative Dermatology (2021) Oct 21 PMID: 34687745

Presentations

Heidi Mansour, PhD, RPh presented "Advances and Innovation in Respiratory Drug Discovery" at the Rocky Mountain Discussion Group (RMDG) American Association of Pharmaceutical Scientists (AAPS) 9th Annual Meeting.

Jason H. Karnes, PharmD, PhD, BCPS, FAHA presented "Precision Medicine in Diverse Populations: Improving Safety, Efficacy, and Discovery" at the Rocky Mountain Discussion Group (RMDG) American Association of Pharmaceutical Scientists (AAPS) 9th Annual Meeting.

Jianqin Lu, BPharm, PhD presented "Nanotechnology-enabled Therapeutics for Improved Cancer Immunochemotherapy" at the Rocky Mountain Discussion Group (RMDG) American Association of Pharmaceutical Scientists (AAPS) 9th Annual Meeting.

David Encinas-Basurto, McCombs, K., Vallorz, E.L., and Heidi Mansour, PhD, RPh presented "Targeting Deep Lungs with Swellable Nano/Microgels for the Delivery of Suramin" at the 2021 Drug Delivery to the Lungs (DDL) International Conference.

Kudos

Heidi Mansour, PhD, RPh recieved new grant award "Improving Health Technology and Research Initiative Fund (TRIF) Grant Award," Sponsor: Senior Vice President (SVP) for Research, Office of Research and Innovation.